U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 47 results

Status:
US Approved Rx (2019)
First approved in 2000

Class (Stereo):
CHEMICAL (ABSOLUTE)



Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. Linezolid appears to be unique in that it blocks the initiation of protein production. Most common adverse react...
Status:
US Approved Rx (2007)
First approved in 1997

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefdinir is an extended-spectrum, semisynthetic cephalosporin, for oral administration. As with other cephalosporins, bactericidal activity of cefdinir results from inhibition of cell wall synthesis. Cefdinir is stable in the presence of some, but no...
Status:
US Approved Rx (2007)
First approved in 1992

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefpodoxime is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. Cefpodoxime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefpodoxime has activity in the presence of ...
Status:
US Approved Rx (2005)
First approved in 1991

Class (Stereo):
CHEMICAL (ABSOLUTE)



Clarithromycin is an antibacterial drug which is used either in combination with lansoprazole and amoxicillin (Prevpac), in combination with omeprazole and amoxicillin (Omeclamox) or alone (Biaxin) for the treatment of broad range of infections. The ...
Status:
US Approved Rx (2018)
First approved in 1991

Class (Stereo):
CHEMICAL (ABSOLUTE)



Azithromycin is one of the world's best-selling antibiotics, used to treat or prevent certain bacterial infections: Acute bacterial exacerbations of chronic bronchitis in adults; acute bacterial sinusitis in adults; uncomplicated skin and skin struct...
Status:
US Approved Rx (2010)
First approved in 1981

Class (Stereo):
CHEMICAL (ABSOLUTE)



Piperacillin is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic which exerts bactericidal activity by inhibiting septum formation and cell wall synthesis of susceptible bacteria. Piperacillin sodium salt is used in com...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Radezolid (RX-1741) is a novel oxazolidinone antibiotic agent and is the first biaryloxazolidinone in clinical development. It is being developed by Rib-X Pharmaceuticals, Inc. for the treatment of serious multi-drug–resistant infections. Radezolid h...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Faropenem medoxomil is an ester prodrug derivative of the beta-lactam antibiotic faropenem. The prodrug form of faropenem offers dramatically improved oral bioavailability and leads to higher systemic concentrations of the drug. Faropenem medoxomil i...
Status:
US Previously Marketed
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



French pharmaceutical company Hoechst Marion Roussel (later Sanofi-Aventis) began phase II/III clinical trials of telithromycin (HMR-3647) in 1998. Telithromycin was approved by the European Commission in July 2001 and subsequently went on sale in Oc...
Status:
US Previously Marketed
First approved in 2003

Class (Stereo):
CHEMICAL (RACEMIC)



Gemifloxacin is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Gemifloxacin mesylate is marketed under the brand name Factive, indicated...